Please login to the form below
report
This page shows the latest report news and features for those working in and with pharma, biotech and healthcare.
Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
Since the first biosimilar arrived in 2015, 30 products have been approved and 21 launched, collectively gaining a significant share in most of their therapeutic areas, says a report released by ... These savings derived mainly from trastuzumab and
Latest news
-
Embattled Biogen talks up Aduhelm
However, the Centers for Medicare and Medicaid Services (CMS) is not expected to release its draft report on the drug until January.
-
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Although follow-up time was not sufficient to report rates after two doses of Vaxzevria, AZ also released additional data showing rates of TTS following a second dose of the vaccine
-
Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
KEYNOTE-522 is the first large randomised phase 3 study to report a statistically significant and clinically meaningful EFS result among patients with stage II and stage III TNBC.
-
AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues
body. There have been 100 reports of the syndrome in people who have received the J&J vaccine, out of nearly 13 million individuals in the US who have received the
-
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
The chance of having this occur is very low.”. According to The New York Times, there have been 100 reports of the syndrome in people who have received the J&J ... According to the US Centers for Disease Control and Prevention (CDC) and FDA, nearly all
Embattled Biogen talks up Aduhelm
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
More from news
Approximately 26 fully matching, plus 2,375 partially matching documents found.
Latest Intelligence
-
Paving the way for the HCP omnichannel experience: a guide for medical affairs
This shift to digital communications looks as if it is here to stay, with a recent report noting that digital communications and virtual meetings between MSLs and HCPs are now a
-
Patient diversity in clinical trials needs to be centre stage
There is a lot to address.”. Understanding all factors. COUCH Health has just published the second issue of its Demand Diversity reports, which is a call to action to tackle the ... The reports, which feature detailed interviews with patients from
-
Diversity and inclusion in clinical trials
Pre-register now for a copy of the report. Nuala Murphy is President, Clinical Research Services, ICON plc.
-
Why we need to look beyond cultural competency to fix the patient diversity challenge
The industry has been aware of underrepresentation since the publication of the unequal treatment public health report in 2003, which has since triggered numerous initiatives to rectify under-representation of minority
-
The pursuit of patient diversity in clinical trials
The report is an attempt to shift the conversation from ‘why’ to ‘how’ – offering a series of recommendations to help companies develop more inclusive trial practices and drive more proportional representation
Paving the way for the HCP omnichannel experience: a guide for medical affairs
Patient diversity in clinical trials needs to be centre stage
Diversity and inclusion in clinical trials
Why we need to look beyond cultural competency to fix the patient diversity challenge
The pursuit of patient diversity in clinical trials
More from intelligence
Approximately 0 fully matching, plus 314 partially matching documents found.
Latest appointments
-
Ogilvy Health appoints Rebecca Carter to newly created head of social media role
Since joining Ogilvy Health, she has been key to growing the agency’s full service offering and leading its ‘social check-up’ report – an analysis of the health and global
-
AZ appoints Alexion’s Aradhana Sarin as chief financial officer
Meanwhile, Sarin will relocate from the US to be based in the UK, and will report to AZ’s chief executive officer Pascal Soriot.
-
Diane DiGangi Trench appointed as country head of Sandoz UK
DiGangi Trench will be based in Sandoz’s headquarters in Camberley, and she will report to Christophe Delenta, the head of cluster I, Sandoz Region Europe.
-
Hanover Health appoints two new associate directors
Both MacDonald and Curran will report to Alex Davies and Emma Gorton, who are both senior directors at Hanover Communications.
-
GCI Health’s UK team announces three senior promotions
Walker, Morris and Yianni will report to Kath Kerry, who was recently named as GCI Health's president of Europe &Middle East.
Ogilvy Health appoints Rebecca Carter to newly created head of social media role
AZ appoints Alexion’s Aradhana Sarin as chief financial officer
Diane DiGangi Trench appointed as country head of Sandoz UK
Hanover Health appoints two new associate directors
GCI Health’s UK team announces three senior promotions
More from appointments
Approximately 0 fully matching, plus 164 partially matching documents found.
Latest from PMHub
-
MarketsResearch.biz
MarketsResearch.Biz is a single destination for all the industry, company and country reports. ... We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.
-
Modernising the Mental Health Act: Published Today
The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018. ... While there is still room for improvement this report gives a positive vision for future of approaches to mental health.”.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
A Rare Disease UK report published in 2016 found that nearly half of the respondents who identified as undiagnosed had been waiting over five years.
-
News:
This multi-country study will report on hospitalised and non-hospitalised patients across core global markets.
-
Rethinking our approach to rare disease communications during COVID-19 and beyond
For example, 35% of patients report difficulties describing their own symptoms and 34% difficulty understanding their doctor’s recommendations without in-person interaction.
More from PMHub
Approximately 6 fully matching, plus 325 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- WHO to test three more potential COVID-19 treatments
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA green lights study of phage-based drug for resistant infections
- First oral antiviral drug for COVID-19 reviewed by Health Canada
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
